ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,523,000 | -52.7% | 140,756 | 0.0% | 6.53% | -32.0% |
| Q4 2015 | $15,901,000 | -88.5% | 140,756 | -88.1% | 9.61% | -73.0% |
| Q3 2015 | $138,718,000 | +52.0% | 1,178,474 | 0.0% | 35.56% | +38.2% |
| Q2 2015 | $91,249,000 | +33.8% | 1,178,474 | 0.0% | 25.74% | +64.0% |
| Q1 2015 | $68,175,000 | +79.4% | 1,178,474 | 0.0% | 15.70% | +50.1% |
| Q4 2014 | $38,006,000 | +31.8% | 1,178,474 | 0.0% | 10.46% | -19.3% |
| Q3 2014 | $28,837,000 | +5.2% | 1,178,474 | -23.8% | 12.96% | -11.5% |
| Q2 2014 | $27,411,000 | -11.4% | 1,545,999 | 0.0% | 14.65% | -8.9% |
| Q1 2014 | $30,935,000 | +19.2% | 1,545,999 | 0.0% | 16.08% | +15.2% |
| Q4 2013 | $25,942,000 | +51.6% | 1,545,999 | -4.0% | 13.96% | +47.8% |
| Q3 2013 | $17,107,000 | +90.0% | 1,610,856 | 0.0% | 9.45% | +41.3% |
| Q2 2013 | $9,005,000 | – | 1,610,856 | – | 6.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |